CLINICAL_TRIALS
trial_result
· 2020-05-04
Clinical Trial Update: Safety of Lactobacillus Reuteri in Healthy Children Aged 2-24 Months [Phase 1]
Summary
Phase 1 trial assessing safety of Lactobacillus reuteri in healthy children aged 2-24 months has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tulane University School of Medicine | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2020-05-04